Variant Bio News Today

EQS-News: Evotec SE / Key word: Quarterly / Interim Statement Evotec reports Q1 2024 results and provides corporate update 22.05.2024 / 07:00 CET/CEST The issuer is...

EQS-News: EVOTEC SE / Key word(s): Quarterly / Interim Statement Evotec reports Q1 2024 results and provides corporate updat...

Interim STATEMENT 3M 2024 HIGHLIGHTS 4 CHALLENGING Q1 WITH...

EQS-News: Evotec SE / Key word: Miscellaneous Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments 18.04.2024 / 13:27...

Dr Megan Leask PhD, Department of Physiology discusses: Precision medicine – medical care tailored to an individual.

To date, the company has built a foundation of more than 20 genomic research partnerships across six continents.

David Moller joins as Chief Scientific Officer and Steve Bryant as Chief Business Officer, adding deep expertise to executive teamSEATTLE--(BUSINESS WIRE)--Variant Bio, a genomics-driven drug discovery company, is transitioning from a company that focused on identifying genomic variants that uncover the basis of dis...

UW Medicine genome experts made significant scientific contributions to a National Institutes of Health Human Genome Research Institute reference collection that better represents the genetic diversity of the world’s populations. Called the Human Pangenome Reference Consortium, the multi-institutional effort expands and updates earlier work that started as the Human Genome Project. In addition to collaborating with many others on the overall pangenome, scientists in the Department of Genome S...

Construction industry news, trends and jobs for building professionals who want mobile-friendly content.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.